[Supportive therapy of urogenital tumors: diagnostic and therapy of common complications].
Within the framework of systemic therapy with cytostatic agents and advanced stages of tumor diseases, therapy-induced and disease-related complications can severely impair the quality of life. This article gives a brief synopsis of the current literature on the diagnosis and therapy concerning anemia thrombotic events and tumor-related hypercalcemia as well as recommendations on treating therapy-associated neutropenia.
Bommer
M
M
Klinik für Innere Medizin III, Universitätsklinikum, Ulm, Deutschland. martin.bommer@uniklinik-ulm.de
Kull
M
M
D000740:Anemia / Q000523:psychology / Q000628:therapy; D006801:Humans; D006934:Hypercalcemia / Q000523:psychology / Q000628:therapy; D009367:Neoplasm Staging; D009503:Neutropenia / Q000523:psychology / Q000628:therapy; D010166:Palliative Care / Q000379:methods*; D011788:Quality of Life / Q000523:psychology; D014565:Urogenital Neoplasms / Q000150:complications / Q000473:pathology / Q000523:psychology / Q000628:therapy*